Cifu A, Prasad V. The Coming A Fib Reversal. JGIM
Huded C, Prasad V. Meta-Analyses of Statin Therapy for Primary Prevention Do Not Answer Key Questions: An Empirical Appraisal of 5 Years of Statin Meta-Analyses. Am J Cardiovasc Drugs. 2015 Jul 4.
Cifu A, Prasad V. Medical Debates and Medical Reversal. JGIM (In Press)
Tilak G, Prasad V, Jena A. Authorship Inflation in Medical Publications. Inquiry: The Journal of Health Care Organization, Provision, and Financing. July 29, 2015, doi: 10.1177/0046958015598311
Oseran A, Prasad V. Variation in Variation of Care Research. Ottawa Journal (In Press)
Prasad V*, Ho N. Why do we continue to adopt medical practices based on pathophysiology alone, when we should be insisting on clinical trials. J Clin Epidemiol. 2014 Apr;67(4):361-3.
Prasad V, Ioannidis JPA. Evidence based de-implementation. Implement Sci. 2014 Jan 8;9(1):1. (See Accompanying Editorial)
Selvaraj S, Borkar D, Prasad V*. Media Coverage of Media Journals: Does the Media Select the best stories? PLoS One. 2014 Jan 17;9(1):e85355.
Prasad V*, Cifu A. Eliminating Chronic Kidney Disease... as a diagnosis. Pol Arch Med Wewn. 2014;124(1-2):7-9.
Prasad V*. Statins, Primary Prevention, Overall Mortality. Ann Intern Med. 2014 Jun 17;160(12):867-9.
Prasad V*. Rosiglitazone, Medical Reversal, and Back to the Basics for Diabetes. AAFP. 2014 Sep 15;90(6):368-70
Prasad V*. But How Many People Died? Health Outcomes in Perspective. Cleveland Clinic Journal of Medicine.
Prasad V*. Medical Practices for Healthy Persons: Why we should consider all of the outcomes. Cleveland Clinic Journal of Medicine. (In Press)
Jena AB, Prasad V, Goldman D, Romley J. Mortality and Treatment Patterns Among Patients Hospitalized With Acute Cardiovascular Conditions During Dates of National Cardiology Meetings. JAMA Internal Medicine. Online 2014 Dec 22
Selvaraj S, Prasad V*. Characteristics of Cluster Randomized Trials. JAMA Intern Med. 2013 Jan 21:1-2. (See Accompanying Editor’s Note)
Huded C, Rosno J, Prasad V*. When Research Evidence is Misleading. Virtual Mentor. 2013 Jan 1;15(1):29-33.
Prasad V*. The Facts are the Facts. CMAJ. 2012 Dec 11;184(18):2029-30
Prasad V*, Rho J, Cifu A. The Inferior vena cava filter: How could a medical device be so well accepted without any evidence of efficacy? JAMA Intern Med. 2013 Apr 8;173(7):493-5.
Prasad V, Jena AB. Pre-specified falsification endpoints: can they validate true observational associations? JAMA. 2013 Jan 16;309(3):241-2.
Prasad V, Jorgenson J, Ioannidis JPA, Cifu, A. Observational studies often make clinical practice recommendations: An empirical evaluation of author attitudes. J Clin Epidemiol. 2013 Apr;66(4):361-366.
Ioannidis JPA, Prasad V. Randomize Health Systems Processes. JAMA Intern Med. 2013 Jul 22;173(14):1279-80.
Prasad V*. The Overdiagnosis of Pneumonia CCJM. Cleve Clin J Med. 2013 Oct;80(10):616-618. (See Accompanying Editorial)
Prasad V*, Ho N. In vitro versus in vivo culture sensitivities: an unchecked assumption? Southwest J Pulm Crit Care. 2013;6(3):125-7.
Kim, J, Rho J, Prasad V*. Portable ultrasounds: Pocket sized, but pocket ready? Am J Med. 2013 Oct;126(10):845-6. . (See Accompanying Editorial)
Rho J, Ho N, Prasad V*. Point/Counterpoint: Were industry-sponsored studies of roflumilast appropriate? No, they fail to answer meaningful clinical questions. CHEST. (In Press)
Prasad V*, The Two Medical Worldviews. Mayo Clin Proc. 2013 Oct;88(10):1046-1050. (See Accompanying Editorial)
Prasad V*, Vandross A, Rho J, Cheung M, Chacko J, Toomey C, Selvaraj S, Quinn S, Borker D, Ho N, Gall V, Cifu A. A decade of reversal. an analysis of 146 contradicted practices Mayo Clinic Proceedings. Mayo Clin Proc. 2013 Jul 12. . (See Accompanying Editorial)
Prasad V*, CIfu A. - Reversals in Cardiology: Interventions that were tried in Vain. Cardiovasc Diagn Ther. 2013 Dec;3(4):228-235.
Prasad V*. The Apples and Oranges of Cost Effectiveness, Cleveland Clinic Journal of Medicine 2012; 79(6):377-379.
Prasad V, Rho J, Cifu A. The Diagnosis and Treatment of Pulmonary Embolism. Archives Internal Medicine. 2012 Jun 25;172(12):955-8.
Prasad V*, Vandross A. Cardiovascular primary prevention: How high should we set the bar. Archives Internal Medicine. 2012;172(8):656-659. (See Accompanying Editorial)
Prasad V*. An Unmeasured Harm of Screening. Archives Internal Medicine. 2012;172(19):1-2.
Prasad V*, Cheung M. Cifu A. Chest pain in the Emergency Room. Archives Internal Medicine.2012;172(19):1-3.
Prasad V*. The conundrum of cost effectiveness. Cleveland Clinic Journal of Medicine 2012; 79(9):610-611
Ho N, Prasad V*.Lacking the incentive to cure? Recurring clostridium difficile diarrhea and our reluctance to utilize fecal transplantation. J Clin Gastroenterol. 2011 Apr;45(4):379-80.
Prasad V, Gall V, Cifu A. The Frequency of Medical Reversal. Archives of Internal Medicine. 2011 Oct 10;171(18):1675-6. (See Accompanying Editorial)
Prasad V, Bonow RO. The cardiovascular biomarker conundrum: challenges and solutions. JAMA. 2011;306(19):2151–2152. (See Accompanying Editorial)
Prasad V, Cifu A. Medical Reversal: Why we must raise the bar before adopting new technologies. The Yale Journal of Biology and Medicine 84 (4), 471.
Prasad V, Cifu A, Ioannidis JPA. Reversals of established medical practices: evidence to abandon ship. JAMA 307 (1), 37-38. (See Accompanying Editorial)
Prasad V, Cifu A. A Medical Burden of Proof: Towards a New Physicans’ Ethic. BioSocieties 7: 72-87. (See Accompanying Editorial)